Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma
Clinical trial NCT05083247 · RECRUITING
Trial details
- NCT number
- NCT05083247
- Sponsor
- Erasme University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-24
- Primary completion
- 2027-12-31
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.